STIFEL FINANCIAL CORP - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 183 filers reported holding CARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$329,987
-34.9%
196,420
+9.6%
0.00%
-100.0%
Q2 2023$507,254
-17.4%
179,241
+43.3%
0.00%0.0%
Q1 2023$614,235
-31.1%
125,099
+50.8%
0.00%0.0%
Q4 2022$891,226
+6.6%
82,982
-7.0%
0.00%0.0%
Q3 2022$836,000
+9.1%
89,275
+6.4%
0.00%0.0%
Q2 2022$766,000
-26.1%
83,889
-1.6%
0.00%0.0%
Q1 2022$1,036,000
+43.5%
85,275
+44.0%
0.00%0.0%
Q4 2021$722,000
-46.7%
59,239
-32.5%
0.00%
-50.0%
Q3 2021$1,355,000
+7.9%
87,722
-0.3%
0.00%0.0%
Q2 2021$1,256,000
-36.1%
87,998
-2.8%
0.00%
-33.3%
Q1 2021$1,965,000
+41.7%
90,508
-1.3%
0.00%
+50.0%
Q4 2020$1,387,000
+24.5%
91,692
+4.8%
0.00%0.0%
Q3 2020$1,114,000
-26.4%
87,524
-1.1%
0.00%
-33.3%
Q2 2020$1,513,000
+32.7%
88,504
+2.7%
0.00%0.0%
Q1 2020$1,140,000
+12.1%
86,193
+36.4%
0.00%
+50.0%
Q4 2019$1,017,000
+5.5%
63,203
+19.7%
0.00%0.0%
Q3 2019$964,000
-6.9%
52,788
+9.9%
0.00%
-33.3%
Q2 2019$1,035,000
+57.8%
48,025
+43.4%
0.00%
+50.0%
Q1 2019$656,000
+46.1%
33,480
-2.7%
0.00%
+100.0%
Q4 2018$449,000
-14.5%
34,415
+57.4%
0.00%
-50.0%
Q3 2018$525,000
+21.5%
21,870
-2.8%
0.00%
+100.0%
Q2 2018$432,000
+24.5%
22,505
-20.0%
0.00%0.0%
Q1 2018$347,000
-27.1%
28,125
-28.0%
0.00%
-50.0%
Q4 2017$476,000
-46.3%
39,065
-39.3%
0.00%
-33.3%
Q3 2017$887,000
-48.5%
64,400
-42.3%
0.00%
-50.0%
Q2 2017$1,724,000
-18.8%
111,555
-3.4%
0.01%
-25.0%
Q1 2017$2,123,000115,4520.01%
Other shareholders
CARA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,193,057$51,440,00039.10%
Chescapmanager LLC 1,299,701$20,938,0003.08%
Burrage Capital Management LLC 284,170$4,578,0003.07%
Cypress Capital Management LLC (WY) 184,085$2,966,0002.80%
DAFNA Capital Management LLC 328,533$5,293,0001.82%
Mesirow Financial Investment Management, Inc. 21,169$341,0001.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 471,575$7,597,0001.14%
AdvisorShares Investments LLC 79,821$1,286,0000.80%
ETF MANAGERS GROUP, LLC 750,680$12,093,0000.42%
FARALLON CAPITAL MANAGEMENT LLC 2,300,000$37,053,0000.25%
View complete list of CARA THERAPEUTICS INC shareholders